| Wednesday July 2, 2003 |
| 08:00-12:30 |
EASL - AGA Symposium
Highlights in Hepatology
|
| |
Chairpersons:
E. Krawitt, USA
D. Schuppan, Germany |
| 08:00-08:30 |
What's new in portal hypertension?
R. Groszmann, USA |
| 08:30-09:00 |
What's new in autoimmune liver disease?
E. Krawitt, USA |
| 09:00-09:30 |
Novel immunosuppressants in hepatology
J. Vierling, USA |
| 09:30-10:00 |
What's new in NASH and ASH?
N. Tözün, Turkey |
| 10:00-10:30 |
Coffee Break |
| 10:30-11:00 |
Pharmacological reversal of fibrosis/cirrhosis
D. Schuppan, Germany |
| 11:00-11:30 |
Gene therapy for hepatocellular carcinoma
J. Prieto, Spain |
| 11:30- 12:00 |
Hepatic stem cells
N. Theise, USA |
| 12:00-12:30 |
Liver Transplantation
H. Bismuth, France |
| 09:00-12:15 |
The 15th Cochrane Hepato-Biliary
Group Meeting |
| |
Chairpersons:
Christian Gluud, Denmark
Luigi Pagliaro, Italy |
| 09:00-09:05 |
Welcome and presentation of the programme
L. Pagliaro, Italy |
| 09:05-09:20 |
The CHBG: achievements and challenges
C. Gluud, Denmark and the CHBG Editors |
| 09:20-09:40 |
How to read a Cochrane systematic Review - understanding the
basics
B. Als-Nielsen, L.L. Kjaergard, C. Gluud, Denmark |
| 09:40-10:00 |
Endoscopic therapy versus pharmacological interventions for
acute variceal bleeding in cirrhosis. The effect of quality
of trials on overall estimates
G. D'Amico, I. Tarantino, L. Pagliaro, Italy |
| 10:00-10:30 |
Coffee Break |
| 10:30-10:50 |
Bile acids for viral hepatitis and primary sclerosing cholangitis
- two Cochrane systematic Reviews
W. Chen, Denmark, J. Liu, China, C. Gluud, Denmark |
| 10:50-11:10 |
Artificial and bioartificial support systems for liver failure
- a Cochrane systematic Review
L.L. Kjaergard, Denmark, J. Liu, China, B. Als-Nielsen, Denmark,
C. Gluud, Denmark |
| 11:10-11:30 |
Methodological quality and intervention effects in 523 randomized
clinical trials
B. Als-Nielsen, W. Chen, L.L. Kjaergard, C. Gluud, Denmark |
| 11:30-11:50 |
Interferon and ribavirin for chronic hepatitis C - an updated
Cochrane systematic Review
J. Brok, L.L. Kjaergard, C. Gluud, Denmark |
| 11:50-12:10 |
Albumin and other plasma expanders for paracentesis treatment
of ascites in cirrhotic patients - a Cochrane systematic Review
R. Simonetti, Italy, L. Pagliaro, Italy, C.
Gluud, Denmark |
| 12:10 |
Discussions and closing of the meeting |
| 12:30-14:00 |
Lunch Break |
| 14:00-19:00 |
EASL - ELTA Meeting |
| |
Prevention and Management of Recurrent Disease
after Liver Transplantation
Chairpersons:
D. Samuel, France
T. Steinmüller, Germany
|
| 14:00-14.10 |
Welcome and introduction President ELTA -
X. Rogiers, Germany |
| 14:10-14:30 |
Re-transplantation for recurrent disease: how important is
the problem? Data from the ELTR registry
T. Steinmüller, Germany |
| 14:30-15:00 |
Disease recurrence: Budd Chiari syndrome
G. Mentha, Switzerland |
| 15:00-15:30 |
Disease recurrence: Hepatitis
B D. Samuel, France |
| 15:30-16:00 |
Disease recurrence: Hepatitis
C C. Trepo, France |
| 16:00-16:30 |
Coffee Break |
| 16:30-17:00 |
Disease recurrence: autoimmune diseases (including PBC and
PSC)
M. Manns, Germany |
| 17:00-17:30 |
Recurrence of alcoholic liver disease
P. Burra, Italy |
| 17:30-18:00 |
Steatosis and steatofibrosis recurrence after transplantation
for non alcoholic steatohepatitis (NASH)
C. Day, UK |
| 18:00-18:30 |
Hepatocellular carcinoma recurrence after transplantation
J.M. Llovet, Spain |
18:30-19:00
|
Closing
J. Bruix, EASL Scientific Secretary, Spain |
Committees
